Evidence map›Paper›PMID 36401361›Full record

ArticleAIDS research and human retroviruses2023

HIV Incidence, Recent HIV Infection, and Associated Factors, Kenya, 2007-2018.

Peter Wesley Young, Paul Musingila, Leonard Kingwara, Andrew C Voetsch, Emily Zielinski-Gutierrez, Marc Bulterys, Andrea A Kim, Megan A Bronson, Bharat S Parekh, Trudy Dobbs and 15 more

Open access · hybridAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 3 countries.

Peter Wesley YoungDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Maputo, Mozambique.ORCID 0000-0002-7432-2876
Paul MusingilaDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Leonard KingwaraNational AIDS & STI Control Programme, Ministry of Health, Nairobi, Kenya.
Andrew C VoetschDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Emily Zielinski-GutierrezDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Marc BulterysDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Andrea A KimDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Megan A BronsonDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Bharat S ParekhDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Trudy DobbsDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Hetal PatelDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Giles ReidSurvey Unit, ICAP at Columbia University, New York, New York, USA.
Thomas AchiaDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Alfred KeterNational AIDS & STI Control Programme, Ministry of Health, Nairobi, Kenya.
Samuel MwaliliDepartment of Statistics and Actuarial Sciences, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
Francis M OgollahSurvey Unit, ICAP at Columbia University, New York, New York, USA.
Raphael OndondoDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Herbert LongweSurvey Unit, ICAP at Columbia University, New York, New York, USA.
Duncan ChegeSurvey Unit, ICAP at Columbia University, New York, New York, USA.
Nancy BowenNational Public Health Laboratory, Ministry of Health, Nairobi, Kenya.
Mamo UmuroNational Public Health Laboratory, Ministry of Health, Nairobi, Kenya.
Catherine NgugiMinistry of Health, Nairobi, Kenya.
Jessica JustmanSurvey Unit, ICAP at Columbia University, New York, New York, USA.
Peter CherutichMinistry of Health, Nairobi, Kenya.
Kevin M De CockDivision of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Centers for Disease Control and Prevention · USCenters for Disease Control and Prevention · KEColumbia University · USMinistry of Health · KENational Aids Control Council · KECenters for Disease Control and Prevention · UGJomo Kenyatta University of Agriculture and Technology · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nationally representative surveys provide an opportunity to assess trends in recent human immunodeficiency virus (HIV) infection based on assays for recent HIV infection. We assessed HIV incidence in Kenya in 2018 and trends in recent HIV infection among adolescents and adults in Kenya using nationally representative household surveys conducted in 2007, 2012, and 2018. To assess trends, we defined a recent HIV infection testing algorithm (RITA) that classified as recently infected (<12 months) those HIV-positive participants that were recent on the HIV-1 limiting antigen (LAg)-avidity assay without evidence of antiretroviral use. We assessed factors associated with recent and long-term (≥12 months) HIV infection versus no infection using a multinomial logit model while accounting for complex survey design. Of 1,523 HIV-positive participants in 2018, 11 were classified as recent. Annual HIV incidence was 0.14% in 2018 [95% confidence interval (CI) 0.057-0.23], representing 35,900 (95% CI 16,300-55,600) new infections per year in Kenya among persons aged 15-64 years. The percentage of HIV infections that were determined to be recent was similar in 2007 and 2012 but fell significantly from 2012 to 2018 [adjusted odds ratio (aOR) = 0.31,

Indexed as

HIV InfectionsHIV SeropositivityAdolescentAdultHumansIncidenceKenyaSexual Partnersantiretroviral treatmentHIV incidence estimationHIV surveillanceKenyapopulation surveystests for recent infection

Identifiers

PMID36401361
PMCPMC9942172
OpenAlexW4309410871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.